Defender Leon Balogun is set to rejoin Rangers pending a successful medical at the Ibrox club. Following Tuesday’s ankle injury that would keep the kid out for a “significant period of time,” the 35-year-old makes a comeback. Although Balogun made no secret of his wish to stay at the club and won the Scottish Premiership and Scottish Cup during his two seasons in Glasgow, he left last summer when his contract was not renewed. Following the expiration of his contract at Loftus Road, the Nigerian international joined QPR last season and, despite practicing with the team this summer, wrote a parting message on Wednesday.
“Thank you to everybody at QPR, including the staff, players, and you, the fans,” Leon Balogun said before his move to Rangers. “I’ve genuinely liked my stay at the club despite all that has transpired over this extremely challenging season. You Rsss, I’m sending you nothing but the best for the future.”
During his first tenure, manager Michael Beale was instrumental in bringing the seasoned defender to Ibrox, and he continues to hold out hope for adding to his team this summer. Rangers have bought six players during this transfer window, and they still have interest in Los Angeles FC midfielder Jose Cifuentes and Nottingham Forest defender Jonathan Panzo. The club is reportedly open to bids for Antonio Colak, Glen Kamara, and Scott Wright in addition to more fresh arrivals anticipated this summer.
Rangers will travel to Rugby Park to take on Kilmarnock to open the 2023–24 Scottish Premiership season. After that, on August 8 or 9, Beale’s team will play the first leg of their Champions League third qualifying round. On August 12, league play will resume when Livingston visits Ibrox. They will play the second leg of their European match on August 15. The first leg will be on August 22 or 23, and the second leg will happen on August 29 or 30 if Rangers advance to the play-off round. After Rangers’ match against Kilmarnock on January 3, the break will resume and expire on January 19.
For more football news, click here
